- Home
- MKDW vs MAIA Comparison
MKDW vs MAIA Comparison
Compare MKDW & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKDW
- MAIA
- Stock Information
- Founded
- MKDW 2006
- MAIA 2018
- Country
- MKDW Taiwan
- MAIA United States
- Employees
- MKDW N/A
- MAIA N/A
- Industry
- MKDW
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- MKDW
- MAIA Health Care
- Exchange
- MKDW NYSE
- MAIA Nasdaq
- Market Cap
- MKDW 40.2M
- MAIA 46.7M
- IPO Year
- MKDW N/A
- MAIA 2022
- Fundamental
- Price
- MKDW $0.32
- MAIA $1.80
- Analyst Decision
- MKDW
- MAIA
- Analyst Count
- MKDW 0
- MAIA 0
- Target Price
- MKDW N/A
- MAIA N/A
- AVG Volume (30 Days)
- MKDW 5.1M
- MAIA 299.5K
- Earning Date
- MKDW 07-21-2025
- MAIA 05-09-2025
- Dividend Yield
- MKDW N/A
- MAIA N/A
- EPS Growth
- MKDW N/A
- MAIA N/A
- EPS
- MKDW N/A
- MAIA N/A
- Revenue
- MKDW $3,670,722.00
- MAIA N/A
- Revenue This Year
- MKDW N/A
- MAIA N/A
- Revenue Next Year
- MKDW N/A
- MAIA N/A
- P/E Ratio
- MKDW N/A
- MAIA N/A
- Revenue Growth
- MKDW 16.40
- MAIA N/A
- 52 Week Low
- MKDW $0.17
- MAIA $1.40
- 52 Week High
- MKDW $5.52
- MAIA $4.31
- Technical
- Relative Strength Index (RSI)
- MKDW N/A
- MAIA 48.82
- Support Level
- MKDW N/A
- MAIA $1.71
- Resistance Level
- MKDW N/A
- MAIA $2.05
- Average True Range (ATR)
- MKDW 0.00
- MAIA 0.11
- MACD
- MKDW 0.00
- MAIA 0.00
- Stochastic Oscillator
- MKDW 0.00
- MAIA 26.47
About MKDW MKDWELL TECH INC
MKDWell Tech Inc is a company engaged in supplying automotive electronics for passenger cars, modified commercial vehicles, camper vans and logistics vehicles. Its business coverage extends across the spectrum of research and development, design, production and sales of automotive electronic products. The main products are intelligent camper vans control systems, LiDAR sensors, intelligent container control systems for logistics vehicles, vehicle seat control system, and it provide customers with ODM and OEM customized services.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.